Peer-reviewedCC BYJCEM case reports
Early parathyroid hormone elevation after denosumab therapy following parathyroidectomy: a diagnostic pitfall
Related
- The use of intraoperative parathyroid hormone assay in predicting the success and reduce morbidity of targeted minimal invasive parathyroidectomy for primary hyperparathyroidism
- Association of intraoperative mitoxantrone hydrochloride injection with incidental parathyroidectomy and parathyroid autotransplantation during gasless unilateral axillary endoscopic thyroidectomy: a propensity score-matched retrospective cohort study
- Preventive strategies for postoperative hypocalcemia and hungry bone syndrome following parathyroidectomy: a systematic review and pairwise meta-analysis
- Autoimmune hepatitis following long-term denosumab therapy in a patient with Hashimoto thyroiditis
- Contralateral atypical femoral fracture following a single dose of denosumab after incomplete teriparatide therapy in a patient with long-term bisphosphonate exposure: A case report
BibTeX
@article{anon2026early,
title = {{Early parathyroid hormone elevation after denosumab therapy following parathyroidectomy: a diagnostic pitfall}},
journal = {JCEM case reports},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13673264},
note = {CC BY},
}
RIS
TY - JOUR
TI - Early parathyroid hormone elevation after denosumab therapy following parathyroidectomy: a diagnostic pitfall
PY - 2026
DA - 2026/10/16
JO - JCEM case reports
UR - https://europepmc.org/article/PMC/PMC13673264
SN - 2755-1520
ER -